AptarGroup, Inc. (NYSE:ATR) Q2 2020 Earnings Conference Call - Final Transcript

Jul 31, 2020 • 09:00 am ET


AptarGroup, Inc. (NYSE:ATR) Q2 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Ladies and gentlemen, thank you for standing by, and welcome to Aptar's 2020 Second Quarter Conference Call. [Operator Instructions]

Introducing today's conference call is Mr. Matt DellaMaria, Senior Vice President, Investor Relations and Communications. Please go ahead, sir.

Matthew DellaMaria

Thank you, and welcome, everyone. Participating on our call today are Stephan Tanda, President and Chief Executive Officer; and Bob Kuhn, Executive Vice President, Chief Financial Officer and Secretary. You can find a copy of our press release as well as a slide presentation file that summarizes our results on our website. If you are following along on the website, you can advance the slides by hovering over the presentation screen and clicking on the arrows on the right and left.

We will also post a replay of this conference call on our website. Today's call includes some forward-looking statements. Please refer to our SEC filings to review factors that could cause actual results to differ materially from those projected or contained in the forward-looking statements. Aptar undertakes no obligation to update the forward-looking information contained therein.

I would now like to turn the conference call over to Stephan.

Stephan Tanda

Thanks, Matt, and good morning, everyone. Thank you for joining us. Let me start by expressing my hope that you and your families are continuing to do well and staying safe during this difficult time. I would also like to take a moment to thank our global workforce for the tremendous dedication and commitment they have shown throughout this pandemic. I am extremely proud of how the entire organization has risen to the challenge so that we could maintain our production, critical drug delivery and dispensing systems for patients and consumers around the world.

Before I comment on the results, I would like to share a few updates related to COVID-19, starting on slide three. We are proud to live up to our purpose and responsibility to society, and as previously shared, we are an essential supplier to several critical industries, including pharmaceuticals and consumer products. Our teams are further motivated by the many expressions of gratitude by our customers for honoring our commitments to them.

To that end, we are constantly adapting our approach, and we recently issued new remote and flexible work guidelines to support our people and to ensure the minimum number of essential on-site employees during this time. We're also thinking of what's coming next, and we have formed several work teams to address the future of work, including the future of customer engagement in the new normal of the post COVID-19 era. Turning now to slide four. You will see but a sample of our global solutions, which are critical to society today. Our drug delivery, dispensing, sealing and active packaging solutions can be found on a number of medicines, sanitizers, cleaners, food and beverage products.

Turning to slide five, I would like to offer a few comments on the quarter. Our Pharma business delivered another strong performance. Core sales grew in our injectables, consumer health care and active